Literature DB >> 16647933

Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse.

Matthew D Barber1, Mark D Walters, Geoffrey W Cundiff.   

Abstract

OBJECTIVE: This study was undertaken to evaluate the responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women with pelvic organ prolapse undergoing surgical and nonsurgical management. STUDY
DESIGN: The responsiveness of the prolapse, urinary and colorectal scales of the PFDI and PFIQ were assessed in 2 independent populations: (1) 42 women with stage II or greater prolapse enrolled in an ongoing multicenter randomized trial comparing 2 different pessaries (Pessary group) and (2) 64 women with stage III or greater prolapse who underwent vaginal reconstructive surgery (Surgery group). All subjects completed the PFDI and PFIQ at baseline and again either 3 months (Pessary group) or 6 months (Surgery group) after initiation of treatment. Responsiveness was assessed with standardized response mean (SRM), effect size (ES), and the paired t test.
RESULTS: In the Pessary group, there was a significant improvement in the prolapse and urinary scales of the PFDI, with each demonstrating moderate responsiveness (prolapse: SRM 0.69, ES 0.68; urinary: SRM 0.57, ES: 0.50, P < .001 for each). The colorectal scale of the PFDI and each of the 3 scales of the PFIQ demonstrated no significant change in scores with pessary use. In the Surgery group, there was a significant improvement in the prolapse, urinary, and colorectal scales of both the PFDI and PFIQ (P < .01 for each). The prolapse and urinary scales of the PFDI demonstrated excellent responsiveness with SRM and ES 1.20 or greater for the prolapse scale and equal to1.05 for the urinary scales. The colorectal scale of the PFDI and the urinary and prolapse scales of the PFIQ demonstrated moderate responsiveness (SRM 0.61-0.70 and ES 0.56-0.60) after surgery. Subjects who had a recurrence of their prolapse develop after surgery (6%) had significantly less improvement in the prolapse scale of the PFDI than those who did not. After controlling for preoperative prolapse stage and baseline quality of life scores, subjects in the Surgery group had significantly greater improvement in each of the scales of the PFDI and the prolapse and urinary scales of the PFIQ than did the Pessary group (P < .05 for each).
CONCLUSION: The PFDI and PFIQ are responsive to change in women undergoing surgical and nonsurgical treatment for pelvic organ prolapse. The PFDI is more responsive than the PFIQ.

Entities:  

Mesh:

Year:  2006        PMID: 16647933     DOI: 10.1016/j.ajog.2006.01.076

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  55 in total

1.  Sexual function in women with anal incontinence using a new instrument: the PISQ-IR.

Authors:  Rachel N Pauls; Rebecca G Rogers; Mitesh Parekh; Joan Pitkin; Dorothy Kammerer-Doak; Peter Sand
Journal:  Int Urogynecol J       Date:  2014-11-13       Impact factor: 2.894

2.  Impact on quality of life after ring pessary use for pelvic organ prolapse.

Authors:  Tarinee Manchana; Suvit Bunyavejchevin
Journal:  Int Urogynecol J       Date:  2012-01-06       Impact factor: 2.894

3.  Responsiveness of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire in women undergoing treatment for pelvic floor disorders.

Authors:  Symphorosa Shing Chee Chan; Rachel Yau Kar Cheung; Beatrice Pui Yee Lai; Lai Loi Lee; Kwong Wai Choy; Tony Kwok Hung Chung
Journal:  Int Urogynecol J       Date:  2012-06-06       Impact factor: 2.894

4.  Pessary use in pelvic organ prolapse and urinary incontinence.

Authors:  Keisha A Jones; Oz Harmanli
Journal:  Rev Obstet Gynecol       Date:  2010

5.  Abdominal Colpopexy: Comparison of Endoscopic Surgical Strategies (ACCESS).

Authors:  E R Mueller; K Kenton; C Tarnay; L Brubaker; A Rosenman; B Smith; K Stroupe; C Bresee; A Pantuck; P Schulam; J T Anger
Journal:  Contemp Clin Trials       Date:  2012-05-27       Impact factor: 2.226

6.  Response to the Letter to the Editor by Waarsenburg et al.

Authors:  Farah Lone; Ranee Thakar; Abdul H Sultan
Journal:  Int Urogynecol J       Date:  2015-09       Impact factor: 2.894

7.  Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial.

Authors:  Holly E Richter; Kathryn L Burgio; Linda Brubaker; Ingrid E Nygaard; Wen Ye; Alison Weidner; Catherine S Bradley; Victoria L Handa; Diane Borello-France; Patricia S Goode; Halina Zyczynski; Emily S Lukacz; Joseph Schaffer; Matthew Barber; Susan Meikle; Cathie Spino
Journal:  Obstet Gynecol       Date:  2010-03       Impact factor: 7.661

8.  Depressive symptoms in women seeking surgery for pelvic organ prolapse.

Authors:  Chiara Ghetti; Jerry L Lowder; Rennique Ellison; M A Krohn; Pamela Moalli
Journal:  Int Urogynecol J       Date:  2010-03-24       Impact factor: 2.894

9.  Association between urinary incontinence and depressive symptoms in overweight and obese women.

Authors:  Vivian W Sung; Delia S West; Alexandra L Hernandez; Thomas L Wheeler; Deborah L Myers; Leslee L Subak
Journal:  Am J Obstet Gynecol       Date:  2009-02-23       Impact factor: 8.661

10.  Evaluating patient learning after an educational program for women with incontinence and pelvic organ prolapse.

Authors:  Roxana Geoffrion; Magali Robert; Sue Ross; Daniela van Heerden; Grace Neustaedter; Selphee Tang; Jill Milne
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.